Related Experiment Video

Updated: Feb 28, 2026

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
06:39

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats

Published on: October 17, 2018

6.9K

[Discirculatory encephalopathy and small vessel disease]

R G Esin1, O R Esin2, I Kh Khairullin2

  • 1Kazan State Medical Academy, Kazan, Russia; Kazan Federal University, Kazan, Russia.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|June 22, 2017
PubMed

Insights

This study evaluates chronic cerebral ischemia, often termed

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • The term 'discirculatory encephalopathy' is used in Russia for chronic cerebral ischemia.
  • Small vessel disease causes slowly progressive cerebral changes.

Purpose of the Study:

  • To assess the clinical utility of 'discirculatory encephalopathy' terminology.
  • To evaluate Ginkgo biloba EGb761 (tanakan) for treating small vessel disease.

Main Methods:

  • Literature review.
  • Analysis of research results.
  • Clinical evaluation of patients with small vessel disease.

Main Results:

  • The term 'discirculatory encephalopathy' requires careful consideration for chronic cerebral ischemia.
  • Ginkgo biloba EGb761 (tanakan) demonstrated effectiveness in patients with small vessel disease.

Conclusions:

  • Standardized Ginkgo biloba EGb761 (tanakan) extract is a viable therapeutic option for small vessel disease.
  • Further standardization of terminology for chronic cerebral ischemia is recommended.

Keywords:
EGb761discirculatory encephalopathysmall vessel diseasetanakan

More Related Videos

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups10:35

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups

Published on: January 12, 2020

9.1K
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

8.3K

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
531